4492 Genetec
- 694
- -6-0.86%
Genetec News
Genetec: Extraordinary Report
Zenetec Research Memo(6): Financial estimates for the March 2025 period expect an increase in revenue and profit against the backdrop of a robust business environment. Business expansion is anticipated through high unit price.
■Future Outlook ● Financial Estimates for the Fiscal Year Ending March 2025 Genetec <4492> estimates financial performance for the fiscal year ending March 2025 will include revenue of 850 million yen (an increase of 18.9% from the previous year), operating profit of 750 million yen (an increase of 19.2% from the previous year), ordinary profit of 730 million yen (an increase of 14.9% from the previous year), and net income attributable to parent company shareholders of 426 million yen (an increase of 2.7% from the previous year). Note that from the first quarter of the fiscal year ending March 2025, the segment including the ERP business will be moved from the traditional system solution business.
Zenitech Research Memo (2): Providing holistic optimization solutions for manufacturing sites in both software and hardware.
Company overview, Stem Inc. <4492> is a company that provides high value-added solutions in system development for electronic products and engineering services for the manufacturing industry based on software and hardware technology and development capabilities, and offers location services using patented technology. The company's businesses are divided into three categories: system solution business, engineering solution business, and GPS business. In the system solution business, software
Genetech Research Memo (1): Significant increase in revenue and profit in the fiscal year ending March 2024, making a strong start as the first year of the medium-term plan.
Company Overview: ZENETEC <4492> is a company that provides high value-added solutions in the electronic product system development, engineering field for manufacturing, and location-based services using patented technology based on software and hardware technology and development capabilities. The company's business is divided into three segments: System Solution Business, Engineering Solution Business, and GPS Business. The System Solution Business
Genetec: Confirmation
Genetech: Securities Report - 39th fiscal year (April 1, 2023 - March 31, 2024).
Genetec Appoints Jason De Souza as Managing Director for Latin America & the Caribbean
Montreal, June 12, 2024 (GLOBE NEWSWIRE) -- Genetec Inc. ("Genetec"), a leading technology provider of unified security, public safety, operations, and business intelligence solutions, today announced the appointment
Genetec Technology's Profit Jumps in March Quarter; Shares Rise 5%
Genetec Technology (KLSE:GENETEC) said its profit attributable to owners jumped to 16.8 million ringgit in the quarter ended March 31 from 10.3 million ringgit a year earlier. Diluted earnings per sha
Genetec's Quarterly Net Profit Jumps 63% on Higher Margin, Sees Rising Demand for Automation and Energy Storage Solutions
Genetec Technology Bhd, whose profit jumped 63.09% year-on-year for the quarter ended March 31, 2024 (4QFY2024), expects continued strong earnings amid increasing demand for its automation and energy storage solutions.
Insider Moves: BCM Alliance Bhd, Fitters Diversified Bhd, Ecofirst Consolidated Bhd, Eduspec Holdings Bhd, Genetec Technology Bhd, OCK Group Bhd
Notable filings Between May 7 and 10, among the notable filings on shareholding changes of companies listed on Bursa Malaysia were those at BCM Alliance Bhd (KL:BCMALL), which saw its largest shareholder Kiu Cu Seng cease to be a shareholder after disposing of a total...
Genetec: Financial results briefing materials for the fiscal year ending March 31, 2024
Genetech --- Announces dividend from surplus (dividend increase)
Genetech ＜4492＞ announced on the 15th that it will pay dividends from surplus funds with 2024/3/31 as the reference date. The company positions return of profits to shareholders as one of the most important management issues, and its basic policy is to allocate profits considering the balance between internal reserves and dividends after considering the business environment, financial situation, and management results. Based on this, the year-end dividend for the fiscal year ending 2024/3 was revised from the most recent dividend forecast of 6.50 yen per share to 14.50 yen, an 8 yen increase, and it is already actual
Brands that moved the day before part 2 Access Group, Sumiseki HD, S-Line G, etc.
<コード>Stock name closing price on the 16th ⇒ compared to the previous day, TESS HOLDINGS ＜5074＞ 395 -41 operating income forecast for the current fiscal year was revised downward. Nissin Flour Milling Group Headquarters ＜2002＞ 1868.5 -174.5 The financial results for the current fiscal year are expected to be flat, and consensus is declining. Optim ＜3694＞ 791 -82 ordinary income for the current fiscal year is expected to be almost flat. Riken NPR ＜6209＞ announced the issuance of 2718-205 stock acquisition rights. Ushio Denki ＜6925＞ 1977-181.5 mac
Genetech --- 2-digit increase in sales and significant profit for the fiscal year ending March 24, sales and profits increased in all segments
Genetech ＜4492＞ announced consolidated financial results for the fiscal year ending 2024/3 on the 15th. Net sales increased 21.9% from the previous fiscal year to 7.147 billion yen, operating profit increased 494.5% to 629 million yen, ordinary profit increased 468.9% to 635 million yen, and net income attributable to parent company shareholders was 414 million yen (profit of 0.23 million yen in the previous fiscal year). Sales in the system solutions business increased 18.2% from the same period last year to 4.496 billion yen, and segment profit increased 39.7% to 974 million yen
Front market [stocks that have moved, stocks that have been created]
*Orchestra ＜6533＞ 1149 Ka - Evaluates good progress in the first quarter results. *Startia H ＜3393＞ 1956 +363 viewed the plan for a significant dividend increase due to the dividend policy change as a positive. *Mitsubishi Kakoki ＜6331＞ 4085 +440 is expected to increase profits continuously this fiscal year due to an upside landing in the previous fiscal year. *M Up ＜3661＞ 1161 +113 is expected to continue to increase drastically in profit this fiscal year. *Nippatsu ＜5991＞ 1751.5 +160.5 early upside landing and this season's big
Front market for high stop and low stop stocks
■Stop High＜1514＞Sumiseki Holdings＜1673＞WisdomTree Gin Exchange Traded Investment Trust ＜1730＞Aso Fromcleat ＜2813＞Kazuhiro Foods ＜6085＞Architects Studio Japan■Stop Yasu＜2708＞Kuze ＜2928＞RIZAP Group ＜4492＞Genetech ＜4598＞Delta-Fly PHARMA ＜6227＞AI Mecatec ＜7069＞Cyber Buzz ＜7687＞Miku Reed ＜9327＞e
Genetec: Notice Concerning Dividends from Surplus Funds
Genetec: Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Genetec FY Net Y414.00M Vs Net Y23.00M
Genetec Corp. (4492.TO) Japan Year Ended March 31 GROUP 2024 2023 Revenue Y7.15 bln Y5.86 bln Operating Profit Y629.00 mln Y105.00 m
Open H, Mitsui Chemicals, Mitsubishi Chemical G, WOWOW (15 days) (1380-4990)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/15 (Wed) ＜1380＞Akigawa Pasture ＜1446＞Candyle＜1447＞itbookHD ＜145A＞ELISBE＜148A＞Hatch Work ＜149A＞Shinka ＜150A＞JSH ＜1514＞Residence
Analysis
Price Target
No Data
